BELGRADE, Mont., June 3, 2015 (GLOBE NEWSWIRE) — Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary biomaterials, today announced the release of ArthroFuse, a patent pending allograft specifically designed for the treatment of hammertoe deformities. Hammertoe

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone